Pursuant to Regulation 29(1) and other applicable regulations, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the meeting of the Board of Directors of the Company will be held on Monday, 27th January, 2025, at the Registered Office of the Company, to consider, approve and take on record: Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December, 2024, along with Limited Review Report of the Statutory Auditors thereon; and to consider and declare Interim Dividend on the equity shares of the Company for the Financial Year 2024-25 and to fix Record Date for the purpose of Interim Dividend, if declared at the Board Meeting; and any other business with the permission of the Chair. The intimation is being given for the information of Shareholders / Members.
The above information is a part of company’s filings submitted to BSE.
